We came across a bullish thesis on ADMA Biologics, Inc. on Stockmindsweb’s YouTube Channel. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.’s share was trading at $17.70 as of January 13th. ADMA’s trailing and forward P/E were 20.58 and 28.99 respectively according to Yahoo Finance.
Nestor Rizhniak/Shutterstock.com
ADMA Biologics is positioned as a differentiated biotech company operating in a sector often marked by volatility and long development...
